Epithelial E- and P-cadherins: Role and clinical significance in cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1826, Issue 2, 2012, Pages 297-311

  Paredes, Joana ^a,b   Figueiredo, Joana ^a   Albergaria, André ^a   Oliveira, Patrícia ^a   Carvalho, Joana ^a   Ribeiro, Ana Sofia ^a   Caldeira, Joana ^a,c   Costa, Angela Margarida ^a   Simões Correia, Joana ^a   Oliveira, Maria José ^c   Pinheiro, Hugo ^a   Pinho, Salomé S ^a   Mateus, Rita ^a   Reis, Celso A ^a,b   Leite, Marina ^a   Fernandes, Maria Sofia ^a   Schmitt, Fernando ^a,b   Carneiro, Fátima ^a,b   Figueiredo, Céu ^a,b   Oliveira, Carla ^a,b   Seruca, Raquel ^a,b   more..

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

Author keywords

Breast; Cancer; E cadherin; Gastric; Hereditary diffuse gastric cancer; P cadherin

Indexed keywords

ANTINEOPLASTIC AGENT; P CADHERIN; PF 03732010; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN INHIBITOR;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MODEL; CANCER SURVIVAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CODE; HELICOBACTER INFECTION; HUMAN; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; LYMPH NODE METASTASIS; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOLECULARLY TARGETED THERAPY; NONHUMAN; P CADHERIN GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; TRANSCRIPTION REGULATION; TUMOR GENE; UVOMORULIN GENE;

BREAST NEOPLASMS; CADHERINS; FEMALE; GENETIC STRUCTURES; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84861800037     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2012.05.002     Document Type: Review

References (241)

1. Cavallaro U., Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 2004, 4:118-132.
2. Gerrow K., El-Husseini A. Cell adhesion molecules at the synapse. Front. Biosci. 2006, 11:2400-2419.
3. Nollet F., Kools P., van Roy F. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J. Mol. Biol. 2000, 299:551-572.
4. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 1993, 5:806-811.
5. Pignatelli M., Bodmer W.F. Genetics and biochemistry of collagen binding-triggered glandular differentiation in a human colon carcinoma cell line. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:5561-5565.
6. Takeichi M. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 1995, 7:619-627.
7. Shapiro L., Fannon A.M., Kwong P.D., Thompson A., Lehmann M.S., Grubel G., Legrand J.F., Als-Nielsen J., Colman D.R., Hendrickson W.A. Structural basis of cell-cell adhesion by cadherins. Nature 1995, 374:327-337.
8. Ozawa M., Ringwald M., Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4246-4250.
9. Blaschuk O.W., Sullivan R., David S., Pouliot Y. Identification of a cadherin cell adhesion recognition sequence. Dev. Biol. 1990, 139:227-229.
10. Ozawa M., Baribault H., Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 1989, 8:1711-1717.
11. Gumbiner B.M., McCrea P.D. Catenins as mediators of the cytoplasmic functions of cadherins. J. Cell Sci. Suppl. 1993, 17:155-158.
12. Yap A.S., Niessen C.M., Gumbiner B.M. The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p120ctn. J. Cell Biol. 1998, 141:779-789.
13. Van Aken E., De Wever O., Correia da Rocha A.S., Mareel M. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch. 2001, 439:725-751.
14. Mareel M., Oliveira M.J., Madani I. Cancer invasion and metastasis: interacting ecosystems. Virchows Arch. 2009, 454:599-622.
15. Makrilia N., Kollias A., Manolopoulos L., Syrigos K. Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest. 2009, 27:1023-1037.
16. Bussemakers M.J., van Bokhoven A., Voller M., Smit F.P., Schalken J.A. The genes for the calcium-dependent cell adhesion molecules P- and E-cadherin are tandemly arranged in the human genome. Biochem. Biophys. Res. Commun. 1994, 203:1291-1294.
17. Berx G., Staes K., van Hengel J., Molemans F., Bussemakers M.J., van Bokhoven A., van Roy F. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 1995, 26:281-289.
18. Jarrard D.F., Paul R., van Bokhoven A., Nguyen S.H., Bova G.S., Wheelock M.J., Johnson K.R., Schalken J., Bussemakers M., Isaacs W.B. P-cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer. Clin. Cancer Res. 1997, 3:2121-2128.
19. Hubbard T.J., Aken B.L., Ayling S., Ballester B., Beal K., Bragin E., Brent S., Chen Y., Clapham P., Clarke L., Coates G., Fairley S., Fitzgerald S., Fernandez-Banet J., Gordon L., Graf S., Haider S., Hammond M., Holland R., Howe K., Jenkinson A., Johnson N., Kahari A., Keefe D., Keenan S., Kinsella R., Kokocinski F., Kulesha E., Lawson D., Longden I., Megy K., Meidl P., Overduin B., Parker A., Pritchard B., Rios D., Schuster M., Slater G., Smedley D., Spooner W., Spudich G., Trevanion S., Vilella A., Vogel J., White S., Wilder S., Zadissa A., Birney E., Cunningham F., Curwen V., Durbin R., Fernandez-Suarez X.M., Herrero J., Kasprzyk A., Proctor G., Smith J., Searle S., Flicek P. Ensembl 2009. Nucleic Acids Res. 2009, 37:D690-D697.
20. Faraldo M.L., Cano A. The 5' flanking sequences of the mouse P-cadherin gene. Homologies to 5' sequences of the E-cadherin gene and identification of a first 215 base-pair intron. J. Mol. Biol. 1993, 231:935-941.
21. van Roy F., Berx G. The cell-cell adhesion molecule E-cadherin. Cell. Mol. Life Sci. 2008, 65:3756-3788.
22. Stemmler M.P. Cadherins in development and cancer. Mol. Biosyst. 2008, 4:835-850.
23. Paredes J., Albergaria A., Oliveira J.T., Jeronimo C., Milanezi F., Schmitt F.C. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin. Cancer Res. 2005, 11:5869-5877.
24. Sakharkar K.R., Chow V.T. PPD-proteome profile database. In Silico Biol. 2004, 4:219-223.
25. Thomas D.J., Rosenbloom K.R., Clawson H., Hinrichs A.S., Trumbower H., Raney B.J., Karolchik D., Barber G.P., Harte R.A., Hillman-Jackson J., Kuhn R.M., Rhead B.L., Smith K.E., Thakkapallayil A., Zweig A.S., Haussler D., Kent W.J. The ENCODE Project at UC Santa Cruz. Nucleic Acids Res. 2007, 35:D663-D667.
26. Oliveira P., Sanges R., Huntsman D., Stupka E., Oliveira C. Characterization of the intronic portion of cadherin superfamily members, common cancer orchestrators. Eur. J. Hum. Genet. 2012, 10.1038/ejhg.2012.11.
27. Hosono S., Gross I., English M.A., Hajra K.M., Fearon E.R., Licht J.D. E-cadherin is a WT1 target gene. J. Biol. Chem. 2000, 275:10943-10953.
28. Liu Y.N., Lee W.W., Wang C.Y., Chao T.H., Chen Y., Chen J.H. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 2005, 24:8277-8290.
29. Behrens J., Lowrick O., Klein-Hitpass L., Birchmeier W. The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:11495-11499.
30. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
31. Hajra K.M., Chen D.Y., Fearon E.R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002, 62:1613-1618.
32. Perez-Moreno M.A., Locascio A., Rodrigo I., Dhondt G., Portillo F., Nieto M.A., Cano A. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J. Biol. Chem. 2001, 276:27424-27431.
33. Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., Mareel M., Huylebroeck D., van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 2001, 7:1267-1278.
34. Eger A., Aigner K., Sonderegger S., Dampier B., Oehler S., Schreiber M., Berx G., Cano A., Beug H., Foisner R. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005, 24:2375-2385.
35. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 2007, 7:415-428.
36. Shi Y., Sawada J., Sui G., Affar el B., Whetstine J.R., Lan F., Ogawa H., Luke M.P., Nakatani Y. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 2003, 422:735-738.
37. Jamora C., DasGupta R., Kocieniewski P., Fuchs E. Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 2003, 422:317-322.
38. Vandewalle C., Comijn J., De Craene B., Vermassen P., Bruyneel E., Andersen H., Tulchinsky E., Van Roy F., Berx G. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005, 33:6566-6578.
39. Aigner K., Dampier B., Descovich L., Mikula M., Sultan A., Schreiber M., Mikulits W., Brabletz T., Strand D., Obrist P., Sommergruber W., Schweifer N., Wernitznig A., Beug H., Foisner R., Eger A. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007, 26:6979-6988.
40. Spaderna S., Schmalhofer O., Wahlbuhl M., Dimmler A., Bauer K., Sultan A., Hlubek F., Jung A., Strand D., Eger A., Kirchner T., Behrens J., Brabletz T. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res. 2008, 68:537-544.
41. Graff J.R., Herman J.G., Lapidus R.G., Chopra H., Xu R., Jarrard D.F., Isaacs W.B., Pitha P.M., Davidson N.E., Baylin S.B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 1995, 55:5195-5199.
42. Shimomura Y., Wajid M., Shapiro L., Christiano A.M. P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle. Development 2008, 135:743-753.
43. Carroll D.K., Carroll J.S., Leong C.O., Cheng F., Brown M., Mills A.A., Brugge J.S., Ellisen L.W. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat. Cell Biol. 2006, 8:551-561.
44. Faraldo M.M., Teuliere J., Deugnier M.A., Birchmeier W., Huelsken J., Thiery J.P., Cano A., Glukhova M.A. Beta-catenin regulates P-cadherin expression in mammary basal epithelial cells. FEBS Lett. 2007, 581:831-836.
45. Le T.L., Yap A.S., Stow J.L. Recycling of E-cadherin: a potential mechanism for regulating cadherin dynamics. J. Cell Biol. 1999, 146:219-232.
46. Bryant D.M., Stow J.L. The ins and outs of E-cadherin trafficking. Trends Cell Biol. 2004, 14:427-434.
47. Hinck L., Nathke I.S., Papkoff J., Nelson W.J. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J. Cell Biol. 1994, 125:1327-1340.
48. Chen Y.T., Stewart D.B., Nelson W.J. Coupling assembly of the E-cadherin/beta-catenin complex to efficient endoplasmic reticulum exit and basal-lateral membrane targeting of E-cadherin in polarized MDCK cells. J. Cell Biol. 1999, 144:687-699.
49. Lock J.G., Stow J.L. Rab11 in recycling endosomes regulates the sorting and basolateral transport of E-cadherin. Mol. Biol. Cell 2005, 16:1744-1755.
50. Bryant D.M., Kerr M.C., Hammond L.A., Joseph S.R., Mostov K.E., Teasdale R.D., Stow J.L. EGF induces macropinocytosis and SNX1-modulated recycling of E-cadherin. J. Cell Sci. 2007, 120:1818-1828.
51. Ling K., Bairstow S.F., Carbonara C., Turbin D.A., Huntsman D.G., Anderson R.A. Type I gamma phosphatidylinositol phosphate kinase modulates adherens junction and E-cadherin trafficking via a direct interaction with mu 1B adaptin. J. Cell Biol. 2007, 176:343-353.
52. Mosesson Y., Mills G.B., Yarden Y. Derailed endocytosis: an emerging feature of cancer. Nat. Rev. Cancer 2008, 8:835-850.
53. Ireton R.C., Davis M.A., van Hengel J., Mariner D.J., Barnes K., Thoreson M.A., Anastasiadis P.Z., Matrisian L., Bundy L.M., Sealy L., Gilbert B., van Roy F., Reynolds A.B. A novel role for p120 catenin in E-cadherin function. J. Cell Biol. 2002, 159:465-476.
54. Davis M.A., Ireton R.C., Reynolds A.B. A core function for p120-catenin in cadherin turnover. J. Cell Biol. 2003, 163:525-534.
55. Xiao K., Garner J., Buckley K.M., Vincent P.A., Chiasson C.M., Dejana E., Faundez V., Kowalczyk A.P. p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Mol. Biol. Cell 2005, 16:5141-5151.
56. Taniuchi K., Nakagawa H., Hosokawa M., Nakamura T., Eguchi H., Ohigashi H., Ishikawa O., Katagiri T., Nakamura Y. Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases. Cancer Res. 2005, 65:3092-3099.
57. Paredes J., Stove C., Stove V., Milanezi F., Van Marck V., Derycke L., Mareel M., Bracke M., Schmitt F. P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer Res. 2004, 64:8309-8317.
58. Palacios F., Price L., Schweitzer J., Collard J.G., D'Souza-Schorey C. An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J. 2001, 20:4973-4986.
59. Figueiredo J., Simoes-Correia J., Soderberg O., Suriano G., Seruca R. ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperones. PLoS One 2011, 6:e23188.
60. Palacios F., Schweitzer J.K., Boshans R.L., D'Souza-Schorey C. ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat. Cell Biol. 2002, 4:929-936.
61. Otsuki Y., Tanaka M., Yoshii S., Kawazoe N., Nakaya K., Sugimura H. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:4385-4390.
62. Morishige M., Hashimoto S., Ogawa E., Toda Y., Kotani H., Hirose M., Wei S., Hashimoto A., Yamada A., Yano H., Mazaki Y., Kodama H., Nio Y., Manabe T., Wada H., Kobayashi H., Sabe H. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat. Cell Biol. 2008, 10:85-92.
63. Daniel J.M., Reynolds A.B. Tyrosine phosphorylation and cadherin/catenin function. Bioessays 1997, 19:883-891.
64. Palacios F., Tushir J.S., Fujita Y., D'Souza-Schorey C. Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol. Cell. Biol. 2005, 25:389-402.
65. Fujita Y., Krause G., Scheffner M., Zechner D., Leddy H.E., Behrens J., Sommer T., Birchmeier W. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol. 2002, 4:222-231.
66. Pinho S.S., Seruca R., Gartner F., Yamaguchi Y., Gu J., Taniguchi N., Reis C.A. Modulation of E-cadherin function and dysfunction by N-glycosylation. Cell. Mol. Life Sci. 2011, 68:1011-1020.
67. Zhu W., Leber B., Andrews D.W. Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis. EMBO J. 2001, 20:5999-6007.
68. Zhou F., Su J., Fu L., Yang Y., Zhang L., Wang L., Zhao H., Zhang D., Li Z., Zha X. Unglycosylation at Asn-633 made extracellular domain of E-cadherin folded incorrectly and arrested in endoplasmic reticulum, then sequentially degraded by ERAD. Glycoconj. J. 2008, 25:727-740.
69. Liwosz A., Lei T., Kukuruzinska M.A. N-glycosylation affects the molecular organization and stability of E-cadherin junctions. J. Biol. Chem. 2006, 281:23138-23149.
70. Pinho S.S., Reis C.A., Paredes J., Magalhaes A.M., Ferreira A.C., Figueiredo J., Xiaogang W., Carneiro F., Gartner F., Seruca R. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum. Mol. Genet. 2009, 18:2599-2608.
71. Pinho S.S., Oliveira P., Cabral J., Carvalho S., Huntsman D., Gartner F., Seruca R., Reis C.A., Oliveira C. Loss and recovery of Mgat3 and GnT-III mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions. PLoS One 2012, 7:e33191.
72. Osumi D., Takahashi M., Miyoshi E., Yokoe S., Lee S.H., Noda K., Nakamori S., Gu J., Ikeda Y., Kuroki Y., Sengoku K., Ishikawa M., Taniguchi N. Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells. Cancer Sci. 2009, 100:888-895.
73. Takeichi M. Functional correlation between cell adhesive properties and some cell surface proteins. J. Cell Biol. 1977, 75:464-474.
74. Hyafil F., Morello D., Babinet C., Jacob F. A cell surface glycoprotein involved in the compaction of embryonal carcinoma cells and cleavage stage embryos. Cell 1980, 21:927-934.
75. Ogou S., Okada T.S., Takeichi M. Cleavage stage mouse embryos share a common cell adhesion system with teratocarcinoma cells. Dev. Biol. 1982, 92:521-528.
76. Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 1988, 102:639-655.
77. Fleming T.P., Javed Q., Hay M. Epithelial differentiation and intercellular junction formation in the mouse early embryo. Dev. Suppl. 1992, 105-112.
78. Aplin J.D., Jones C.J., Harris L.K. Adhesion molecules in human trophoblast-a review. I. Villous trophoblast. Placenta 2009, 30:293-298.
79. Nose A., Takeichi M. A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos. J. Cell Biol. 1986, 103:2649-2658.
80. Larue L., Ohsugi M., Hirchenhain J., Kemler R. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:8263-8267.
81. Riethmacher D., Brinkmann V., Birchmeier C. A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:855-859.
82. Radice G.L., Ferreira-Cornwell M.C., Robinson S.D., Rayburn H., Chodosh L.A., Takeichi M., Hynes R.O. Precocious mammary gland development in P-cadherin-deficient mice. J. Cell Biol. 1997, 139:1025-1032.
83. Frebourg T., Oliveira C., Hochain P., Karam R., Manouvrier S., Graziadio C., Vekemans M., Hartmann A., Baert-Desurmont S., Alexandre C., Lejeune Dumoulin S., Marroni C., Martin C., Castedo S., Lovett M., Winston J., Machado J.C., Attie T., Jabs E.W., Cai J., Pellerin P., Triboulet J.P., Scotte M., Le Pessot F., Hedouin A., Carneiro F., Blayau M., Seruca R. Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer. J. Med. Genet. 2006, 43:138-142.
84. Kjaer K.W., Hansen L., Schwabe G.C., Marques-de-Faria A.P., Eiberg H., Mundlos S., Tommerup N., Rosenberg T. Distinct CDH3 mutations cause ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome). J. Med. Genet. 2005, 42:292-298.
85. Sprecher E., Bergman R., Richard G., Lurie R., Shalev S., Petronius D., Shalata A., Anbinder Y., Leibu R., Perlman I., Cohen N., Szargel R. Hypotrichosis with juvenile macular dystrophy is caused by a mutation in CDH3, encoding P-cadherin. Nat. Genet. 2001, 29:134-136.
86. Nelson W.J. Epithelial cell polarity from the outside looking in. News Physiol. Sci. 2003, 18:143-146.
87. Hirai Y., Nose A., Kobayashi S., Takeichi M. Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. II. Skin morphogenesis. Development 1989, 105:271-277.
88. Berx G., Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 2001, 3:289-293.
89. Shimoyama Y., Hirohashi S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res. 1991, 51:2185-2192.
90. Hines M.D., Jin H.C., Wheelock M.J., Jensen P.J. Inhibition of cadherin function differentially affects markers of terminal differentiation in cultured human keratinocytes. J. Cell Sci. 1999, 112(Pt 24):4569-4579.
91. Ribeiro A.S., Albergaria A., Sousa B., Correia A.L., Bracke M., Seruca R., Schmitt F.C., Paredes J. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene 2010, 29:392-402.
92. Moll R., Mitze M., Frixen U.H., Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am. J. Pathol. 1993, 143:1731-1742.
93. Gamallo C., Palacios J., Suarez A., Pizarro A., Navarro P., Quintanilla M., Cano A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am. J. Pathol. 1993, 142:987-993.
94. Reis-Filho J.S., Cancela Paredes J., Milanezi F., Schmitt F.C. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer 2002, 94:2114-2115.
95. author reply 2115-2116.
96. Weigelt B., Geyer F.C., Natrajan R., Lopez-Garcia M.A., Ahmad A.S., Savage K., Kreike B., Reis-Filho J.S. The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type. J. Pathol. 2010, 220:45-57.
97. Simpson P.T., Reis-Filho J.S., Lambros M.B., Jones C., Steele D., Mackay A., Iravani M., Fenwick K., Dexter T., Jones A., Reid L., Da Silva L., Shin S.J., Hardisson D., Ashworth A., Schmitt F.C., Palacios J., Lakhani S.R. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J. Pathol. 2008, 215:231-244.
98. Mahler-Araujo B., Savage K., Parry S., Reis-Filho J.S. Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype. J. Clin. Pathol. 2008, 61:615-620.
99. Lopes N., Carvalho J., Duraes C., Sousa B., Gomes M., Costa J.L., Oliveira C., Paredes J., Schmitt F. 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation. Anticancer. Res. 2012, 32:249-257.
100. Berx G., Cleton-Jansen A.M., Strumane K., de Leeuw W.J., Nollet F., van Roy F., Cornelisse C. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996, 13:1919-1925.
101. Keller G., Vogelsang H., Becker I., Hutter J., Ott K., Candidus S., Grundei T., Becker K.F., Mueller J., Siewert J.R., Hofler H. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am. J. Pathol. 1999, 155:337-342.
102. Schrader K.A., Masciari S., Boyd N., Wiyrick S., Kaurah P., Senz J., Burke W., Lynch H.T., Garber J.E., Huntsman D.G. Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam. Cancer 2008, 7:73-82.
103. Becker K.F., Atkinson M.J., Reich U., Becker I., Nekarda H., Siewert J.R., Hofler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994, 54:3845-3852.
104. Becker K.F., Kremmer E., Eulitz M., Becker I., Handschuh G., Schuhmacher C., Muller W., Gabbert H.E., Ochiai A., Hirohashi S., Hofler H. Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody. Am. J. Pathol. 1999, 155:1803-1809.
105. Machado J.C., Carneiro F., Beck S., Rossi S., Lopes J., Taveira-Gomes A., Cardoso-Oliveira M. E-cadherin expression is correlated with the isolated cell/diffuse histotype and with features of biological aggressiveness of gastric carcinoma. Int. J. Surg. Pathol. 1998, 6:135-144.
106. Carneiro F., Machado J.C., Seruca R., Sobrinho-Simoes M. E-cadherin changes in gastric carcimona. Histopathology 1999, 35:477-478.
107. Carvalho J., van Grieken N.C., Pereira P.M., Sousa S., Tijssen M., Buffart T.E., Diosdado B., Grabsch H., Santos M.A., Meijer G., Seruca R., Carvalho B., Oliveira C. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 upregulation in intestinal gastric cancer. J. Pathol. 2012, 10.1002/path.4032.
108. Machado J.C., Oliveira C., Carvalho R., Soares P., Berx G., Caldas C., Seruca R., Carneiro F., Sobrinho-Simoes M. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001, 20:1525-1528.
109. Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., Taite H., Scoular R., Miller A., Reeve A.E. E-cadherin germline mutations in familial gastric cancer. Nature 1998, 392:402-405.
110. Oliveira C., Senz J., Kaurah P., Pinheiro H., Sanges R., Haegert A., Corso G., Schouten J., Fitzgerald R., Vogelsang H., Keller G., Dwerryhouse S., Grimmer D., Chin S.F., Yang H.K., Jackson C.E., Seruca R., Roviello F., Stupka E., Caldas C., Huntsman D. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum. Mol. Genet. 2009, 18:1545-1555.
111. Pinheiro H., Bordeira-Carrico R., Seixas S., Carvalho J., Senz J., Oliveira P., Inacio P., Gusmao L., Rocha J., Huntsman D., Seruca R., Oliveira C. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum. Mol. Genet. 2010, 19:943-952.
112. Guilford P., Humar B., Blair V. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice. Gastric Cancer 2010, 13:1-10.
113. Suriano G., Seixas S., Rocha J., Seruca R. A model to infer the pathogenic significance of CDH1 germline missense variants. J. Mol. Med. 2006, 84:1023-1031.
114. Suriano G., Oliveira C., Ferreira P., Machado J.C., Bordin M.C., De Wever O., Bruyneel E.A., Moguilevsky N., Grehan N., Porter T.R., Richards F.M., Hruban R.H., Roviello F., Huntsman D., Mareel M., Carneiro F., Caldas C., Seruca R. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum. Mol. Genet. 2003, 12:575-582.
115. Suriano G., Oliveira M.J., Huntsman D., Mateus A.R., Ferreira P., Casares F., Oliveira C., Carneiro F., Machado J.C., Mareel M., Seruca R. E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum. Mol. Genet. 2003, 12:3007-3016.
116. Brooks-Wilson A.R., Kaurah P., Suriano G., Leach S., Senz J., Grehan N., Butterfield Y.S., Jeyes J., Schinas J., Bacani J., Kelsey M., Ferreira P., MacGillivray B., MacLeod P., Micek M., Ford J., Foulkes W., Australie K., Greenberg C., LaPointe M., Gilpin C., Nikkel S., Gilchrist D., Hughes R., Jackson C.E., Monaghan K.G., Oliveira M.J., Seruca R., Gallinger S., Caldas C., Huntsman D. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J. Med. Genet. 2004, 41:508-517.
117. Kaurah P., MacMillan A., Boyd N., Senz J., De Luca A., Chun N., Suriano G., Zaor S., Van Manen L., Gilpin C., Nikkel S., Connolly-Wilson M., Weissman S., Rubinstein W.S., Sebold C., Greenstein R., Stroop J., Yim D., Panzini B., McKinnon W., Greenblatt M., Wirtzfeld D., Fontaine D., Coit D., Yoon S., Chung D., Lauwers G., Pizzuti A., Vaccaro C., Redal M.A., Oliveira C., Tischkowitz M., Olschwang S., Gallinger S., Lynch H., Green J., Ford J., Pharoah P., Fernandez B., Huntsman D. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007, 297:2360-2372.
118. Corso G., Roviello F., Paredes J., Pedrazzani C., Novais M., Correia J., Marrelli D., Cirnes L., Seruca R., Oliveira C., Suriano G. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management. Eur. J. Surg. Oncol. 2007, 33:1061-1067.
119. More H., Humar B., Weber W., Ward R., Christian A., Lintott C., Graziano F., Ruzzo A.M., Acosta E., Boman B., Harlan M., Ferreira P., Seruca R., Suriano G., Guilford P. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum. Mutat. 2007, 28:203.
120. Oliveira C., de Bruin J., Nabais S., Ligtenberg M., Moutinho C., Nagengast F.M., Seruca R., van Krieken H., Carneiro F. Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour. Oncogene 2004, 23:2236-2240.
121. Barber M., Murrell A., Ito Y., Maia A.T., Hyland S., Oliveira C., Save V., Carneiro F., Paterson A.L., Grehan N., Dwerryhouse S., Lao-Sirieix P., Caldas C., Fitzgerald R.C. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J. Pathol. 2008, 216:295-306.
122. Oliveira C., Sousa S., Pinheiro H., Karam R., Bordeira-Carrico R., Senz J., Kaurah P., Carvalho J., Pereira R., Gusmao L., Wen X., Cipriano M.A., Yokota J., Carneiro F., Huntsman D., Seruca R. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009, 136:2137-2148.
123. Grady W.M., Willis J., Guilford P.J., Dunbier A.K., Toro T.T., Lynch H., Wiesner G., Ferguson K., Eng C., Park J.G., Kim S.J., Markowitz S. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat. Genet. 2000, 26:16-17.
124. Peinado H., Ballestar E., Esteller M., Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol. Cell. Biol. 2004, 24:306-319.
125. Fujii S., Ochiai A. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells. Cancer Sci. 2008, 99:738-746.
126. Cao Q., Yu J., Dhanasekaran S.M., Kim J.H., Mani R.S., Tomlins S.A., Mehra R., Laxman B., Cao X., Kleer C.G., Varambally S., Chinnaiyan A.M. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 2008, 27:7274-7284.
127. Pena C., Garcia J.M., Silva J., Garcia V., Rodriguez R., Alonso I., Millan I., Salas C., de Herreros A.G., Munoz A., Bonilla F. E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum. Mol. Genet. 2005, 14:3361-3370.
128. Liu Y., Hong Y., Zhao Y., Ismail T.M., Wong Y., Eu K.W. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines. Cancer Invest. 2008, 26:575-582.
129. von Burstin J., Eser S., Paul M.C., Seidler B., Brandl M., Messer M., von Werder A., Schmidt A., Mages J., Pagel P., Schnieke A., Schmid R.M., Schneider G., Saur D. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. Gastroenterology 2009, 137:361-371. (371 e361-365).
130. Herranz N., Pasini D., Diaz V.M., Franci C., Gutierrez A., Dave N., Escriva M., Hernandez-Munoz I., Di Croce L., Helin K., Garcia de Herreros A., Peiro S. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol. Cell. Biol. 2008, 28:4772-4781.
131. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
132. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5:522-531.
133. Hurteau G.J., Carlson J.A., Spivack S.D., Brock G.J. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res. 2007, 67:7972-7976.
134. Korpal M., Lee E.S., Hu G., Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008, 283:14910-14914.
135. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10:593-601.
136. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22:894-907.
137. Tan H.X., Wang Q., Chen L.Z., Huang X.H., Chen J.S., Fu X.H., Cao L.Q., Chen X.L., Li W., Zhang L.J. MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med. Oncol. 2010, 27:654-660.
138. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., Teruya-Feldstein J., Reinhardt F., Onder T.T., Valastyan S., Westermann F., Speleman F., Vandesompele J., Weinberg R.A. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 2010, 12:247-256.
139. Oki Y., Issa J.P. Epigenetic mechanisms in AML-a target for therapy. Cancer Treat. Res. 2010, 145:19-40.
140. Simoes-Correia J., Figueiredo J., Oliveira C., van Hengel J., Seruca R., van Roy F., Suriano G. Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer. Hum. Mol. Genet. 2008, 17:3566-3576.
141. Sitia R., Braakman I. Quality control in the endoplasmic reticulum protein factory. Nature 2003, 426:891-894.
142. Meusser B., Hirsch C., Jarosch E., Sommer T. ERAD: the long road to destruction. Nat. Cell Biol. 2005, 7:766-772.
143. van Hengel J., van Roy F. Diverse functions of p120ctn in tumors. Biochim. Biophys. Acta 2007, 1773:78-88.
144. Jawhari A.U., Noda M., Pignatelli M., Farthing M. Up-regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120(ctn) in gastric carcinoma. J. Pathol. 1999, 189:180-185.
145. Karayiannakis A.J., Syrigos K.N., Alexiou D., Kalahanis N., Rosenberg T., Bastounis E., Pignatelli M. Expression patterns of the novel catenin p120cas in gastrointestinal cancers. Anticancer. Res. 1999, 19:4401-4405.
146. Karatzas G., Karayiannakis A.J., Syrigos K.N., Chatzigianni E., Papanikolaou S., Simatos G., Papanikolaou D., Bogris S. Expression patterns of the E-cadherin-catenin cell-cell adhesion complex in gastric cancer. Hepatogastroenterology 2000, 47:1465-1469.
147. Apweiler R., Hermjakob H., Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1999, 1473:4-8.
148. Dube D.H., Bertozzi C.R. Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 2005, 4:477-488.
149. Pinho S.S., Osorio H., Nita-Lazar M., Gomes J., Lopes C., Gartner F., Reis C.A. Role of E-cadherin N-glycosylation profile in a mammary tumor model. Biochem. Biophys. Res. Commun. 2009, 379:1091-1096.
150. Iijima J., Zhao Y., Isaji T., Kameyama A., Nakaya S., Wang X., Ihara H., Cheng X., Nakagawa T., Miyoshi E., Kondo A., Narimatsu H., Taniguchi N., Gu J. Cell-cell interaction-dependent regulation of N-acetylglucosaminyltransferase III and the bisected N-glycans in GE11 epithelial cells. Involvement of E-cadherin-mediated cell adhesion. J. Biol. Chem. 2006, 281:13038-13046.
151. Yoshimura M., Ihara Y., Matsuzawa Y., Taniguchi N. Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J. Biol. Chem. 1996, 271:13811-13815.
152. Giles R.H., van Es J.H., Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 2003, 1653:1-24.
153. Reynolds A.B., Roczniak-Ferguson A. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene 2004, 23:7947-7956.
154. Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J. 2003, 22:2318-2323.
155. Gottardi C.J., Wong E., Gumbiner B.M. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J. Cell Biol. 2001, 153:1049-1060.
156. Stockinger A., Eger A., Wolf J., Beug H., Foisner R. E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J. Cell Biol. 2001, 154:1185-1196.
157. Suriano G., Mulholland D., de Wever O., Ferreira P., Mateus A.R., Bruyneel E., Nelson C.C., Mareel M.M., Yokota J., Huntsman D., Seruca R. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene 2003, 22:5716-5719.
158. Sahai E., Marshall C.J. RHO-GTPases and cancer. Nat. Rev. Cancer 2002, 2:133-142.
159. Deplazes J., Fuchs M., Rauser S., Genth H., Lengyel E., Busch R., Luber B. Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation. Hum. Mol. Genet. 2009, 18:3632-3644.
160. Mateus A.R., Seruca R., Machado J.C., Keller G., Oliveira M.J., Suriano G., Luber B. EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells. Hum. Mol. Genet. 2007, 16:1639-1647.
161. Mateus A.R., Simoes-Correia J., Figueiredo J., Heindl S., Alves C.C., Suriano G., Luber B., Seruca R. E-cadherin mutations and cell motility: a genotype-phenotype correlation. Exp. Cell Res. 2009, 315:1393-1402.
162. Crepaldi T., Pollack A.L., Prat M., Zborek A., Mostov K., Comoglio P.M. Targeting of the SF/HGF receptor to the basolateral domain of polarized epithelial cells. J. Cell Biol. 1994, 125:313-320.
163. Pece S., Gutkind J.S. Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J. Biol. Chem. 2000, 275:41227-41233.
164. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
165. Qian X., Karpova T., Sheppard A.M., McNally J., Lowy D.R. E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J. 2004, 23:1739-1748.
166. Takahashi K., Suzuki K. Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion. Exp. Cell Res. 1996, 226:214-222.
167. Mook O.R., Frederiks W.M., Van Noorden C.J. The role of gelatinases in colorectal cancer progression and metastasis. Biochim. Biophys. Acta 2004, 1705:69-89.
168. Munshi H.G., Ghosh S., Mukhopadhyay S., Wu Y.I., Sen R., Green K.J., Stack M.S. Proteinase suppression by E-cadherin-mediated cell-cell attachment in premalignant oral keratinocytes. J. Biol. Chem. 2002, 277:38159-38167.
169. Lochter A., Galosy S., Muschler J., Freedman N., Werb Z., Bissell M.J. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 1997, 139:1861-1872.
170. Davies G., Jiang W.G., Mason M.D. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin. Cancer Res. 2001, 7:3289-3297.
171. Noe V., Fingleton B., Jacobs K., Crawford H.C., Vermeulen S., Steelant W., Bruyneel E., Matrisian L.M., Mareel M. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J. Cell Sci. 2001, 114:111-118.
172. Ryniers F., Stove C., Goethals M., Brackenier L., Noe V., Bracke M., Vandekerckhove J., Mareel M., Bruyneel E. Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. Biol. Chem. 2002, 383:159-165.
173. Comoglio P.M., Boccaccio C., Trusolino L. Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr. Opin. Cell Biol. 2003, 15:565-571.
174. Ferreira P., Oliveira M.J., Beraldi E., Mateus A.R., Nakajima T., Gleave M., Yokota J., Carneiro F., Huntsman D., Seruca R., Suriano G. Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro. Exp. Cell Res. 2005, 310:99-104.
175. Ferreira A.C., Suriano G., Mendes N., Gomes B., Wen X., Carneiro F., Seruca R., Machado J.C. E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2. Hum. Mol. Genet. 2012, 21:334-343.
176. Huang F.Y., Chan A.O., Rashid A., Wong D.K., Cho C.H., Yuen M.F. Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1beta activation of nitric oxide production in gastric cancer cells. Cancer 2012, 10.1002/cncr.27519.
177. Chan A.O., Lam S.K., Wong B.C., Wong W.M., Yuen M.F., Yeung Y.H., Hui W.M., Rashid A., Kwong Y.L. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003, 52:502-506.
178. Leung W.K., Man E.P., Yu J., Go M.Y., To K.F., Yamaoka Y., Cheng V.Y., Ng E.K., Sung J.J. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin. Cancer Res. 2006, 12:3216-3221.
179. Perri F., Cotugno R., Piepoli A., Merla A., Quitadamo M., Gentile A., Pilotto A., Annese V., Andriulli A. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am. J. Gastroenterol. 2007, 102:1361-1371.
180. Chan A.O., Peng J.Z., Lam S.K., Lai K.C., Yuen M.F., Cheung H.K., Kwong Y.L., Rashid A., Chan C.K., Wong B.C. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006, 55:463-468.
181. Schirrmeister W., Gnad T., Wex T., Higashiyama S., Wolke C., Naumann M., Lendeckel U. Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection. Exp. Cell Res. 2009, 315:3500-3508.
182. Hoy B., Lower M., Weydig C., Carra G., Tegtmeyer N., Geppert T., Schroder P., Sewald N., Backert S., Schneider G., Wessler S. Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion. EMBO Rep. 2010, 11:798-804.
183. O'Connor P.M., Lapointe T.K., Jackson S., Beck P.L., Jones N.L., Buret A.G. Helicobacter pylori activates calpain via toll-like receptor 2 to disrupt adherens junctions in human gastric epithelial cells. Infect. Immun. 2011, 79:3887-3894.
184. Conlin V.S., Curtis S.B., Zhao Y., Moore E.D., Smith V.C., Meloche R.M., Finlay B.B., Buchan A.M. Helicobacter pylori infection targets adherens junction regulatory proteins and results in increased rates of migration in human gastric epithelial cells. Infect. Immun. 2004, 72:5181-5192.
185. Suzuki M., Mimuro H., Suzuki T., Park M., Yamamoto T., Sasakawa C. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J. Exp. Med. 2005, 202:1235-1247.
186. Franco A.T., Israel D.A., Washington M.K., Krishna U., Fox J.G., Rogers A.B., Neish A.S., Collier-Hyams L., Perez-Perez G.I., Hatakeyama M., Whitehead R., Gaus K., O'Brien D.P., Romero-Gallo J., Peek R.M. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10646-10651.
187. Murata-Kamiya N., Kurashima Y., Teishikata Y., Yamahashi Y., Saito Y., Higashi H., Aburatani H., Akiyama T., Peek R.M., Azuma T., Hatakeyama M. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007, 26:4617-4626.
188. Sokolova O., Bozko P.M., Naumann M. Helicobacter pylori suppresses glycogen synthase kinase 3beta to promote beta-catenin activity. J. Biol. Chem. 2008, 283:29367-29374.
189. Ogden S.R., Wroblewski L.E., Weydig C., Romero-Gallo J., O'Brien D.P., Israel D.A., Krishna U.S., Fingleton B., Reynolds A.B., Wessler S., Peek R.M. p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7. Mol. Biol. Cell 2008, 19:4110-4121.
190. Bebb J.R., Leach L., Zaitoun A., Hand N., Letley D.P., Thomas R., Atherton J.C. Effects of Helicobacter pylori on the cadherin-catenin complex. J. Clin. Pathol. 2006, 59:1261-1266.
191. Oliveira M.J., Costa A.M., Costa A.C., Ferreira R.M., Sampaio P., Machado J.C., Seruca R., Mareel M., Figueiredo C. CagA associates with c-Met, E-cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype. J. Infect. Dis. 2009, 200:745-755.
192. Oliveira M.J., Costa A.C., Costa A.M., Henriques L., Suriano G., Atherton J.C., Machado J.C., Carneiro F., Seruca R., Mareel M., Leroy A., Figueiredo C. Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner. J. Biol. Chem. 2006, 281:34888-34896.
193. Jang A.C., Starz-Gaiano M., Montell D.J. Modeling migration and metastasis in Drosophila. J. Mammary Gland Biol. Neoplasia 2007, 12:103-114.
194. Pereira P.S., Teixeira A., Pinho S., Ferreira P., Fernandes J., Oliveira C., Seruca R., Suriano G., Casares F. E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and Notch pathways in Drosophila epithelia. Hum. Mol. Genet. 2006, 15:1704-1712.
195. Caldeira J., Pereira P.S., Suriano G., Casares F. Using fruitflies to help understand the molecular mechanisms of human hereditary diffuse gastric cancer. Int. J. Dev. Biol. 2009, 53:1557-1561.
196. Humar B., Blair V., Charlton A., More H., Martin I., Guilford P. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res. 2009, 69:2050-2056.
197. Mbalaviele G., Dunstan C.R., Sasaki A., Williams P.J., Mundy G.R., Yoneda T. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res. 1996, 56:4063-4070.
198. Perl A.K., Wilgenbus P., Dahl U., Semb H., Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998, 392:190-193.
199. Kuwabara Y., Yamada T., Yamazaki K., Du W.L., Banno K., Aoki D., Sakamoto M. Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis. Cancer Sci. 2008, 99:1933-1939.
200. Shimoyama Y., Hirohashi S., Hirano S., Noguchi M., Shimosato Y., Takeichi M., Abe O. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 1989, 49:2128-2133.
201. Sanders D.S., Bruton R., Darnton S.J., Casson A.G., Hanson I., Williams H.K., Jankowski J. Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma. Int. J. Cancer 1998, 79:573-579.
202. Rocha A.S., Soares P., Machado J.C., Maximo V., Fonseca E., Franssila K., Sobrinho-Simoes M. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Virchows Arch. 2002, 440:498-504.
203. Kim M.A., Jung E.J., Lee H.S., Lee H.E., Yang H.K., Oh D.Y., Bang Y.J., Kim W.H. P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance. Hum. Pathol. 2010, 41:877-885.
204. Imai K., Hirata S., Irie A., Senju S., Ikuta Y., Yokomine K., Harao M., Inoue M., Tsunoda T., Nakatsuru S., Nakagawa H., Nakamura Y., Baba H., Nishimura Y. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers. Clin. Cancer Res. 2008, 14:6487-6495.
205. Lo Muzio L., Campisi G., Farina A., Rubini C., Pannone G., Serpico R., Laino G., De Lillo A., Carinci F. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. BMC Cancer 2005, 5:63.
206. Han A.C., Edelson M.I., Peralta Soler A., Knudsen K.A., Lifschitz-Mercer B., Czernobilsky B., Rosenblum N.G., Salazar H. Cadherin expression in glandular tumors of the cervix. Cancer 2000, 89:2053-2058.
207. Longatto Filho A., Albergaria A., Paredes J., Moreira M.A., Milanezi F., Schmitt F.C. P-cadherin expression in glandular lesions of the uterine cervix detected by liquid-based cytology. Cytopathology 2005, 16:88-93.
208. Stefansson I.M., Salvesen H.B., Akslen L.A. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. J. Clin. Oncol. 2004, 22:1242-1252.
209. Moreno-Bueno G., Hardisson D., Sarrio D., Sanchez C., Cassia R., Prat J., Herman J.G., Esteller M., Matias-Guiu X., Palacios J. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J. Pathol. 2003, 199:471-478.
210. Quattrocchi L., Green A.R., Martin S., Durrant L., Deen S. The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression. Virchows Arch. 2011, 459:21-29.
211. Sarrio D., Moreno-Bueno G., Sanchez-Estevez C., Banon-Rodriguez I., Hernandez-Cortes G., Hardisson D., Palacios J. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas. Hum. Pathol. 2006, 37:1042-1049.
212. Soler A.P., Harner G.D., Knudsen K.A., McBrearty F.X., Grujic E., Salazar H., Han A.C., Keshgegian A.A. Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology. Am. J. Pathol. 1997, 151:471-478.
213. Bryan R.T., Atherfold P.A., Yeo Y., Jones L.J., Harrison R.F., Wallace D.M., Jankowski J.A. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies. J. Pathol. 2008, 215:184-194.
214. Matos I., Dufloth R., Alvarenga M., Zeferino L.C., Schmitt F. p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 2005, 447:688-694.
215. Arnes J.B., Brunet J.S., Stefansson I., Begin L.R., Wong N., Chappuis P.O., Akslen L.A., Foulkes W.D. Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clin. Cancer Res. 2005, 11:4003-4011.
216. Palacios J., Benito N., Pizarro A., Suarez A., Espada J., Cano A., Gamallo C. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am. J. Pathol. 1995, 146:605-612.
217. Peralta Soler A., Knudsen K.A., Salazar H., Han A.C., Keshgegian A.A. P-cadherin expression in breast carcinoma indicates poor survival. Cancer 1999, 86:1263-1272.
218. Paredes J., Milanezi F., Reis-Filho J.S., Leitao D., Athanazio D., Schmitt F. Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer?. Pathol. Res. Pract. 2002, 198:795-801.
219. Kovacs A., Dhillon J., Walker R.A. Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas. Mol. Pathol. 2003, 56:318-322.
220. Gamallo C., Moreno-Bueno G., Sarrio D., Calero F., Hardisson D., Palacios J. The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Mod. Pathol. 2001, 14:650-654.
221. Paredes J., Correia A.L., Ribeiro A.S., Milanezi F., Cameselle-Teijeiro J., Schmitt F.C. Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival. J. Clin. Pathol. 2008, 61:856-862.
222. Foulkes W.D., Stefansson I.M., Chappuis P.O., Begin L.R., Goffin J.R., Wong N., Trudel M., Akslen L.A. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J. Natl. Cancer Inst. 2003, 95:1482-1485.
223. Lakhani S.R., Reis-Filho J.S., Fulford L., Penault-Llorca F., van der Vijver M., Parry S., Bishop T., Benitez J., Rivas C., Bignon Y.J., Chang-Claude J., Hamann U., Cornelisse C.J., Devilee P., Beckmann M.W., Nestle-Kramling C., Daly P.A., Haites N., Varley J., Lalloo F., Evans G., Maugard C., Meijers-Heijboer H., Klijn J.G., Olah E., Gusterson B.A., Pilotti S., Radice P., Scherneck S., Sobol H., Jacquemier J., Wagner T., Peto J., Stratton M.R., McGuffog L., Easton D.F. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin. Cancer Res. 2005, 11:5175-5180.
224. Palacios J., Honrado E., Osorio A., Cazorla A., Sarrio D., Barroso A., Rodriguez S., Cigudosa J.C., Diez O., Alonso C., Lerma E., Sanchez L., Rivas C., Benitez J. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clin. Cancer Res. 2003, 9:3606-3614.
225. Palacios J., Honrado E., Osorio A., Cazorla A., Sarrio D., Barroso A., Rodriguez S., Cigudosa J.C., Diez O., Alonso C., Lerma E., Dopazo J., Rivas C., Benitez J. Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Res. Treat. 2005, 90:5-14.
226. Gorski J.J., James C.R., Quinn J.E., Stewart G.E., Staunton K.C., Buckley N.E., McDyer F.A., Kennedy R.D., Wilson R.H., Mullan P.B., Harkin D.P. BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer. Breast Cancer Res. Treat. 2010, 122:721-731.
227. Albergaria A., Ribeiro A.S., Pinho S., Milanezi F., Carneiro V., Sousa B., Sousa S., Oliveira C., Machado J.C., Seruca R., Paredes J., Schmitt F. ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation. Hum. Mol. Genet. 2010, 19:2554-2566.
228. Sato N., Fukushima N., Maitra A., Matsubayashi H., Yeo C.J., Cameron J.L., Hruban R.H., Goggins M. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res. 2003, 63:3735-3742.
229. Milicic A., Harrison L.A., Goodlad R.A., Hardy R.G., Nicholson A.M., Presz M., Sieber O., Santander S., Pringle J.H., Mandir N., East P., Obszynska J., Sanders S., Piazuelo E., Shaw J., Harrison R., Tomlinson I.P., McDonald S.A., Wright N.A., Jankowski J.A. Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo. Cancer Res. 2008, 68:7760-7768.
230. Van Marck V., Stove C., Van Den Bossche K., Stove V., Paredes J., Vander Haeghen Y., Bracke M. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer Res. 2005, 65:8774-8783.
231. Sarrio D., Palacios J., Hergueta-Redondo M., Gomez-Lopez G., Cano A., Moreno-Bueno G. Functional characterization of E- and P-cadherin in invasive breast cancer cells. BMC Cancer 2009, 9:74.
232. Bauer K., Dowejko A., Bosserhoff A.K., Reichert T.E., Bauer R.J. P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation. Carcinogenesis 2009, 30:1781-1788.
233. Bauer K., Dowejko A., Bosserhoff A.K., Reichert T.E., Bauer R. Slit-2 facilitates interaction of P-cadherin with Robo-3 and inhibits cell migration in an oral squamous cell carcinoma cell line. Carcinogenesis 2011, 32:935-943.
234. Mandeville J.A., Silva Neto B., Vanni A.J., Smith G.L., Rieger-Christ K.M., Zeheb R., Loda M., Libertino J.A., Summerhayes I.C. P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells. BJU Int. 2008, 102:1707-1714.
235. Cheung L.W., Leung P.C., Wong A.S. Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer. Oncogene 2010, 29:2427-2440.
236. Reynolds A.B., Daniel J.M., Mo Y.Y., Wu J., Zhang Z. The novel catenin p120cas binds classical cadherins and induces an unusual morphological phenotype in NIH3T3 fibroblasts. Exp. Cell Res. 1996, 225:328-337.
237. Baki L., Marambaud P., Efthimiopoulos S., Georgakopoulos A., Wen P., Cui W., Shioi J., Koo E., Ozawa M., Friedrich V.L., Robakis N.K. Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2381-2386.
238. Jacobs K., Van Gele M., Forsyth R., Brochez L., Vanhoecke B., De Wever O., Bracke M. P-cadherin counteracts myosin II-B function: implications in melanoma progression. Mol. Cancer 2010, 9:255.
239. Radice G.L., Sauer C.L., Kostetskii I., Peralta Soler A., Knudsen K.A. Inappropriate P-cadherin expression in the mouse mammary epithelium is compatible with normal mammary gland function. Differentiation 2003, 71:361-373.
240. Gregory D.J., Mikhaylova L., Fedulov A.V. Selective DNA demethylation by fusion of TDG with a sequence-specific DNA-binding domain. Epigenetics 2012, 7.
241. Zhang C.C., Yan Z., Zhang Q., Kuszpit K., Zasadny K., Qiu M., Painter C.L., Wong A., Kraynov E., Arango M.E., Mehta P.P., Popoff I., Casperson G.F., Los G., Bender S., Anderes K., Christensen J.G., VanArsdale T. PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity. Clin. Cancer Res. 2010, 16:5177-5188.